These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3436171)

  • 1. Renal plasma flow and glomerular filtration rate during antihypertensive therapy in essential hypertension.
    Pedersen EB; Danielsen H; Eiskjaer H; Jespersen B; Sørensen SS; Thomsen OO
    Dan Med Bull; 1987 Dec; 34 Suppl 1():7-8. PubMed ID: 3436171
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective measurement of glomerular filtration rate and effective renal plasma flow during treatment of malignant essential hypertension.
    Ghose RR
    Postgrad Med J; 1984 Oct; 60(708):662-4. PubMed ID: 6494086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in central hemodynamics and renal blood flow after correction of arterial hypertension with diltiazem].
    Ivleva AIa; Gavrilova EN; Krasnobaeva GM; Shatkovskiĭ NP; Gaĭdamakina NE
    Sov Med; 1989; (5):70-3. PubMed ID: 2675337
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M; Hollenberg NK
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute oliguric renal failure due to accelerated (malignant) hypertension.
    Sevitt LH; Evans DJ; Wrong OM
    Q J Med; 1971 Jan; 40(157):127-44. PubMed ID: 5090541
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive drugs and kidney function].
    Belovezhdov N
    Vutr Boles; 1990; 29(6):1-7. PubMed ID: 1982594
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of short-term and long-term treatment with metoprolol on renal blood flow and glomerular filtration rate in hypertensive patients with a normal kidney function.
    Strandgaard S; Elmgreen J; Christensen TE; Laursen SW
    Dan Med Bull; 1982 Oct; 29(6):287-9. PubMed ID: 7140383
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects and therapy of the hypertensive emergency].
    Stumpe KO
    Internist (Berl); 1984 Jun; 25(6):359-66. PubMed ID: 6384105
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
    Mosley C; O'Connor DT; Taylor A; Slutsky RA; Cervenka J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S757-61. PubMed ID: 6084120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension.
    Navis GJ; de Jong PE; Donker AJ; de Zeeuw D
    Proc Eur Dial Transplant Assoc; 1983; 20():577-81. PubMed ID: 6318224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal effects of nifedipine, a calcium antagonist, administered as anti-hypertensive drug].
    Yokoyama S; Mori N; Takayama S; Hosino T; Kaburagi T
    Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1451-7. PubMed ID: 4094169
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal hemodynamic changes induced by hypertension and its treatment.
    Pessina AC; Semplicini A; Palatini P; Samà B; Mozzato MG; Rossi GP; Casiglia E
    Am J Hypertens; 1989 Feb; 2(2 Pt 2):77S-81S. PubMed ID: 2645911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of blood pressure-lowering treatment of essential hypertension on kidney vasculature and kidney function].
    Birkenhäger WH
    Verh K Acad Geneeskd Belg; 1994; 56(3):165-85; discussion 185-90. PubMed ID: 8053262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period.
    Lloveras JJ; Durand D; Ader JL; Tran Van T; Rostaing L; Cerene A; Fournial G; Suc JM
    Transplant Proc; 1993 Jun; 25(3):2226. PubMed ID: 8516879
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension.
    Kubo SH; Cody RJ; Covit AB; Feldschuh J; Laragh JH
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):38S-46S. PubMed ID: 3794764
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.
    Morrone LF; Ramunni A; Fassianos E; Saracino A; Coratelli P; Passavanti G
    J Hum Hypertens; 2003 Jul; 17(7):487-93. PubMed ID: 12821956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone on GFR and renal plasma flow in man.
    Hirschberg R; Kopple JD
    Kidney Int Suppl; 1987 Oct; 22():S21-4. PubMed ID: 3323614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.